COLL - Company ID 0001267565
The table below shows COLLEGIUM PHARMACEUTICAL, INC's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $129.47M | $268.65M | $150.10M | $117.35M | $96.19M | $38.96M |
| Short-term investments | $0.00 | $153.10M | $135.77M | $104.81M | $101.58M | $81.00M |
| Receivables | $285.10M | $228.76M | $233.95M | $213.02M | $228.71M | $228.46M |
| Inventory | $113.27M | $42.74M | $38.05M | $38.15M | $37.22M | $38.03M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $608.01M |
| $745.67M |
| $613.87M |
| $549.21M |
| $527.55M |
| $443.81M |
| Property, plant & equipment | $10.65M | $11.66M | $12.25M | $12.90M | $13.85M | $14.61M |
| Goodwill | $190.18M | $145.93M | $145.93M | $147.94M | $150.76M | $145.96M |
| Total assets | $2.14B | $1.65B | $1.61B | $1.59B | $1.63B | $1.64B |
| Accounts payable | $9.24M | $6.83M | $7.65M | $10.89M | $17.85M | $3.14M |
| Total current liabilities | $589.86M | $434.97M | $452.93M | $464.61M | $486.71M | $459.43M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $1.82B | $1.34B | $1.33B | $1.36B | $1.40B | $1.40B |
| Retained earnings | -$101.68M | -$86.63M | -$118.09M | -$149.60M | -$161.58M | -$176.53M |
| Total equity | $311.91M | $312.42M | $274.81M | $232.21M | $234.43M | $234.28M |